Andrew McMichael
14Patents
5h-index
18Co-inventors
63Inventor score
Filing activity: Dec 31, 1992 → Jun 29, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6663871B1 | Methods and reagents for vaccination which generate a CD8 T cell immune response | Emerging Cross-Sectional Technologies | 21 | Expired |
| US7981430B2 | Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome | Chemistry; Metallurgy | 10 | Active |
| US7993651B2 | Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopes | Chemistry; Metallurgy | 8 | Expired |
| US5395751A | Assay for cytotoxic T cells | Physics | 6 | Expired |
| US5700635A | HIV-1 gag cytotoxic T-lymphocyte epitope and method of use | Chemistry; Metallurgy | 6 | Expired |
| US7410767B1 | HLA-E binding | Physics | 3 | Expired |
| US5459238A | Peptide fragments of HIV | Emerging Cross-Sectional Technologies | 3 | Expired |
| US10010606B2 | Mosaic conserved region HIV immunogenic polypeptides | Chemistry; Metallurgy | 2 | Active |
| US7407661B2 | Methods and reagents that generate a CD8 T cell immune response | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7514087B2 | Methods and reagents for immunization which generate a CD8 T cell immune response | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5683701A | Peptide fragments of HIV | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5972351A | Plasmodium falciparum MHC class I-restricted CTL epitopes derived from pre-erythrocytic stage antigens | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11235055B2 | Nucleic acids encoding mosaic conserved region HIV immunogenic polypeptides | Chemistry; Metallurgy | 0 | Active |
| US8728485B2 | Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.